Dr. Elias Sayour, MD, PhD
Claim this profileUniversity of Florida
Area of expertise
Brain Tumor
Elias Sayour, MD, PhD has run 8 trials for Brain Tumor. Some of their research focus areas include:
Brain Cancer
Elias Sayour, MD, PhD has run 5 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Florida
UF Health Shands Children's Hospital
Clinical Trials Elias Sayour, MD, PhD is currently running
Adoptive Cellular Therapy
for Brain Cancer
A Phase I open-label, multicenter study, to evaluate the safety, feasibility, and maximum tolerated dose (MTD) of treating children with newly diagnosed DIPG or recurrent neuroblastoma with molecular targeted therapy in combination with adoptive cell therapy (Total tumor mRNA-pulsed autologous Dendritic Cells (DCs) (TTRNA-DCs), Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT) and Autologous G-CSF mobilized Hematopoietic Stem Cells (HSCs)).
Recruiting
1 award
Phase 1
16 criteria
Trametinib + Everolimus
for Recurrent Brain Cancer
This phase I trial studies the side effects and best dose of trametinib and everolimus in treating pediatric and young adult patients with gliomas that have come back (recurrent). Trametinib acts by targeting a protein in cells called MEK and disrupting tumor growth. Everolimus is a drug that may block another pathway in tumor cells that can help tumors grow. Giving trametinib and everolimus may work better to treat low and high grade gliomas compared to trametinib or everolimus alone.
Recruiting
1 award
Phase 1
35 criteria
More about Elias Sayour, MD, PhD
Clinical Trial Related
6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Elias Sayour, MD, PhD has experience with
- TTRNA-xALT
- TTRNA-DC Vaccines With GM-CSF
- Trametinib
- Cyclophosphamide + Fludarabine Lymphodepletive Conditioning
- Dose-Intensified TMZ
- Everolimus
Breakdown of trials Elias Sayour, MD, PhD has run
Brain Tumor
Brain Cancer
Diffuse Intrinsic Pontine Glioma
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elias Sayour, MD, PhD specialize in?
Elias Sayour, MD, PhD focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are IDH positive.
Is Elias Sayour, MD, PhD currently recruiting for clinical trials?
Yes, Elias Sayour, MD, PhD is currently recruiting for 3 clinical trials in Gainesville Florida. If you're interested in participating, you should apply.
Are there any treatments that Elias Sayour, MD, PhD has studied deeply?
Yes, Elias Sayour, MD, PhD has studied treatments such as TTRNA-xALT, TTRNA-DC vaccines with GM-CSF, Trametinib.
What is the best way to schedule an appointment with Elias Sayour, MD, PhD?
Apply for one of the trials that Elias Sayour, MD, PhD is conducting.
What is the office address of Elias Sayour, MD, PhD?
The office of Elias Sayour, MD, PhD is located at: University of Florida, Gainesville, Florida 32610-0265 United States. This is the address for their practice at the University of Florida.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.